Article Text

PDF

Determinants of self-reported smoking and misclassification during pregnancy, and analysis of optimal cut-off points for urinary cotinine: a cross-sectional study
  1. Juan J Aurrekoetxea1,2,3,
  2. Mario Murcia4,5,
  3. Marisa Rebagliato4,5,
  4. María José López4,6,7,
  5. Ane Miren Castilla4,8,
  6. Loreto Santa-Marina1,3,4,
  7. Mónica Guxens4,9,10,
  8. Ana Fernández-Somoano4,11,
  9. Mercedes Espada8,
  10. Aitana Lertxundi2,3,4,
  11. Adonina Tardón4,11,
  12. Ferran Ballester4,5,12
  1. 1Public Health Department, Basque Government, San Sebastian, Spain
  2. 2University of Basque Country UPV/EHU, San Sebastian, Spain
  3. 3Health Research Institute (BIODONOSTIA), San Sebastian, Spain
  4. 4Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Spain
  5. 5Center for Public Health Research (CSISP), Valencia, Spain
  6. 6Public Health Agency of Barcelona, Barcelona, Spain
  7. 7Institute of Biomedical Research (IIB Sant Pau), Barcelona, Spain
  8. 8Public Health Laboratory of Bilbao, Bilbao, Spain
  9. 9Center for Research in Environmental Epidemiology (CREAL), Barcelona, Spain
  10. 10Hospital del Mar Research Institute (IMIM), Barcelona, Spain
  11. 11Department of Preventive Medicine and Public Health, University of Oviedo, Oviedo, Spain
  12. 12Department of Nursing, University of Valencia, Valencia, Spain
  1. Correspondence to Dr Juan J Aurrekoetxea; jj.aurreko{at}gmail.com

Abstract

Objectives To estimate the prevalence and factors associated with smoking and misclassification in pregnant women from INMA (INfancia y Medio Ambiente, Environment and Childhood) project, Spain, and to assess the optimal cut-offs for urinary cotinine (UC) that best distinguish daily and occasional smokers with varying levels of second-hand smoke (SHS) exposure.

Design We used logistic regression models to study the relationship between sociodemographic variables and self-reported smoking and misclassification (self-reported non-smokers with UC >50 ng/ml). Receiver operating characteristic (ROC) curves were used to calculate the optimal cut-off point for discriminating smokers. The cut-offs were also calculated after stratification among non-smokers by the number of sources of SHS exposure. The cut-off points used to discriminate smoking status were the level of UC given by Youden's index and for 50 and 100 ng/ml for daily smokers, or 25 and 50 ng/ml for occasional smokers.

Participants At the third trimester of pregnancy, 2263 pregnant women of the INMA Project were interviewed between 2004 and 2008 and a urine sample was collected.

Results Prevalence of self-reported smokers at the third trimester of pregnancy was 18.5%, and another 3.9% misreported their smoking status. Variables associated with self-reported smoking and misreporting were similar, including born in Europe, educational level and exposure to SHS. The optimal cut-off was 82 ng/ml (95% CI 42 to 133), sensitivity 95.2% and specificity 96.6%. The area under the ROC curve was 0.986 (95% CI 0.982 to 0.990). The cut-offs varied according to the SHS exposure level being 42 (95% CI 27 to 57), 82 (95% CI 46 to 136) and 106 ng/ml (95% CI 58 to 227) for not being SHS exposed, exposed to one, and to two or more sources of SHS, respectively. The optimal cut-off for discriminating occasional smokers from non-smokers was 27 ng/ml (95% CI 11 to 43).

Conclusions Prevalence of smoking during pregnancy in Spain remains high. UC is a reliable biomarker for classifying pregnant women according to their smoking status. However, cut-offs would differ based on baseline exposure to SHS.

  • Epidemiology
  • Public Health
  • Toxicology
  • Preventive Medicine

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.

Statistics from Altmetric.com

Article summary

Article focus

  • There is no current consensus regarding the cut-off point for urinary cotinine in pregnant women able to discriminate regular or occasional smokers from non-smokers.

  • These cut-offs would also differ according to baseline exposure to second-hand smoke (SHS).

  • This study assesses the maternal factors influencing both self-reported and misclassification of smoking and evaluate the optimal cut-off point for urinary cotinine that best distinguishes smokers from non-smokers, according to the frequency of smoking and SHS exposure.

Key messages

  • The prevalence of both smoking (18.5%) and SHS exposure (45.9%) was high in a population-based sample of pregnant women in Spain.

  • Factors associated with self-reported smoking and misreporting were similar, including lower level of education and living in a smoking environment, which highlights the need of reinforcing the preventive interventions and policies.

  • The optimal cut-off point to discriminate smokers from non-smokers varied according to the frequency of smoking (occasional or daily smokers) and SHS exposure levels.

  • This study highlights the importance of SHS exposure for selecting reference cut-offs to discriminate smoking status, especially in high-SHS-exposed populations.

Strengths and limitations of this study

  • This study has the ability to assess the role of baseline exposures to SHS in the estimate of cut-offs, given the detailed information collected on SHS exposure and its elevated prevalence.

  • This study uses population-based samples of pregnant women from the INfancia y Medio Ambiente birth cohort, which might not be fully representative of all pregnant women in the study areas.

Introduction

Risks for mother and fetus have been widely related to smoking during pregnancy.1 Several studies have indicated that pregnant women tend to under-report their consumption of tobacco,2–8 owing to social pressure9 or to avoid criticism from health professionals.3 Indeed, it is known to be a higher rate of misreporting of smoking among the groups in which it is not considered as acceptable, such as pregnant women and patients with smoking-related diseases.9

Cotinine is the main metabolite of nicotine and the biomarker of choice for distinguishing smokers from non-smokers and for assessing exposure to second-hand smoke (SHS).10 Women's clearance of cotinine is faster during pregnancy11 and their plasma half-life is a little less than 9 h.12 For this reason, urinary cotinine (UC) tests may give false negatives in pregnant women who have not recently smoked.

There is no current consensus regarding the cut-off point for UC in pregnant women. Several thresholds have been proposed, with 50 ng/ml being the most widely used.13–16 On the other hand, Higgins et al17 proposed 25 ng/ml as the cut-off point, while Gorber et al9 underlined the need to decide on a suitable threshold for pregnant women in particular, for whom the sensitivity of the test may be different, and also suggested that a new cut-off point should be established for occasional smokers. Spierto et al18 found 79 ng/ml as the cut-off between non-smoking and smoking pregnant women.

The aims of our study were (1) to assess the prevalence of self-reported smoking and the UC levels in a cohort of pregnant women; (2) to assess the prevalence of misclassification of maternal smoking status according to the most widely accepted cut-off point in the literature of 50 ng/ml, and to study maternal factors associated with both self-reported and misclassification of maternal smoking and (3) to identify the optimal cut-off point for UC that best distinguishes smokers from non-smokers in our study sample, according to the frequency of smoking (occasional or daily smokers) and SHS exposure.

Methods

Study population

The INMA (INfancia y Medio Ambiente, Environment and Childhood) project is a Spanish multicentre prospective birth cohort study which aims to evaluate the impact of exposure to the most prevalent environmental pollutants, and the role of diet on fetal and infant growth, health and development.19 From eligible pregnant women recruited between 2003 and 2008, 56% agreed to participate. The inclusion criteria were at least 16 years of age, singleton pregnancy, enrolment at 10–13 weeks of gestation, no assisted conception, delivery scheduled at the reference hospital and no communication handicap. There was no upper age limit for becoming a member of the cohort. Of the 2644 women who agreed to participate in the study, 119 (4.5%) were lost (59 miscarriages, 8 fetal death, 47 withdrew and 5 lost to follow-up). Around week 32 of their pregnancy, 2263 of the 2525 remaining women completed, between 2004 and 2008, a questionnaire on smoking and other variables and provided urine samples for determination of UC (figure 1). The hospital ethics committee of each centre approved the research protocol, and all pregnant women gave written informed consent before inclusion at the first trimester of pregnancy.

Figure 1

Flow chart of the INfancia y Medio Ambiente birth cohort in relation to smoking and urinary cotinine quantification.

Information concerning smoking

Questionnaire on tobacco consumption included smoking history, patterns of consumption (occasional or regular) and exposure to SHS. We considered the women who, at this interview, reported smoking occasionally or daily to be smokers, regardless of their UC levels. Women who had UC levels higher than the widely used level of 50 ng/ml to distinguish smokers from non-smokers,13–16 but who did not report smoking, were classed as misclassified. It was considered that the participants were exposed to SHS when they reported exposure at least twice a week in any of the following environments: at work, at home or in leisure time outside the home (eg, bars/restaurants or other homes). We analysed whether women had any passive exposure to tobacco smoke (yes or no) and also the number of exposure sources, between 0 and 3, according to the reported places of exposure: at work, at home and/or elsewhere in leisure time.

Urinary cotinine

The urine samples were collected in the same interview in the morning during the third trimester of pregnancy. Urine was collected in 100 ml polyethylene containers and stored at −20°C. One aliquot of the sample from each of the participants was sent to the Public Health Laboratory of Bilbao (Spain) to be analysed. All urine samples were stored for a minimum of 1 year and a maximum of 5 years before analysis. The analysis of the UC was performed by competitive enzyme immunoassay (EIA) using commercial EIA microplate test kits (OraSure Technologies, Inc, Bio-Rad) for determining salivary cotinine adapted for urine samples using urine controls (0, 2.5, 10 and 50 ng/ml, Bio-Rad). Samples with UC levels above 50 ng/ml were diluted. Before testing the urine samples, the method was validated; a certified reference material was used (EPA/NIST Reference Material 8444) to evaluate the repeatability and reproducibility. The quantification limit was 4.0 ng/ml, the coefficient of repeatability 7% and the reproducibility 10%.

Other variables

The women were interviewed twice during pregnancy (in the first and third trimesters of gestation) to obtain information about their sociodemographic characteristics and lifestyle variables. Social status of the women (or her partner, if she had never worked outside home) was defined using Spanish adaptation of the British classification system.20

Statistical analysis

The χ2 test was used to test hypotheses for categorical variables, whereas differences in the distribution of UC, according to categorical covariates, were evaluated using the Mann-Whitney U and the Kruskal Wallis tests. In order to identify the variables independently associated with being either a smoker, a misclassified or both, logistic regression models were built including geographical area and the variables related with the outcome at p<0.10 in the univariate analysis, and sequentially excluding those variables not related at p<0.10 in the adjusted model using the likelihood ratio test. For comparability purposes, variables remaining at p<0.10 in any of the models were entered in all the models. For ordinal categorical variables, the p for a linear trend was also calculated.

We used the non-parametric receiver operating characteristic (ROC) curve to analyse the relationship between the sensitivity (probability of a positive test among smokers) and false-positive (probability of a positive test among non-smokers, 1-specificity) cases for various different cut-off points that dichotomise UC to distinguish smokers from non-smokers, using self-reported cigarette-smoking status as the reference value. Overall accuracy was evaluated by means of the area under the curve (AUC) (showing the ability of the urinary cotinine to correctly classify smoking status with varying cut-off points.21 The optimal cut-off point for UC to discriminate smokers from non-smokers was the value (c) associated with Youden's index (J), defined by: J=maximum{sensitivity(c)+specificity(c)–1}.22 This value is ‘optimal’ in the sense that it maximises the overall rate of correct classification in the absence of a loss function (ie, giving the same weight to errors of sensitivity and specificity). Since the shape of the distribution of the estimator of the optimal cut-off point was unknown, we used the percentile bootstrap method, with 2000 resampling simulations, to establish 95% CI, with the aid of the ‘boot’ package of R.23 Additionally, the data were analysed for the most widely used cut-off points, namely 50 and 100 ng/ml, or 25 and 50 ng/ml when analyses were restricted to occasional smokers. The cut-off points were also calculated after stratification among non-smokers for SHS exposure in three groups: 798 women that referred not exposed to SHS, 735 exposed to one source of SHS and 303 exposed to more than one source. Additional sensitivity analyses were conducted (see online supplementary table), the first one excluding 1047 pregnant women non-smokers who referred SHS exposure, the second one excluding 317 self-reported non-smokers who claimed to have stopped smoking during pregnancy, since this group is more likely to misreport their smoking status, and the last one excluding 35 women who declared that they did not smoke but had implausible UC levels in non smokers (>500 ng/ml). Assuming α=0.05, 95% CI were calculated for ORs, cut-off points and area under the ROC curve. All statistical tests were two-sided. Statistical analysis was carried out using SPSS (V.17.0) and R (2.11.1) statistical software.

Results

Study setting and characteristics of the sample

Overall, 61.2% of women reported to have smoked at least once in their life, whereas 32.4% were occasional or regular smokers when they became pregnant, falling to 19.7% at the first trimester and 18.5% at the third trimester of their pregnancy (table 1).

Table 1

Description of the sample and variables of interest

Smoking and SHS exposure

The median UC level in women who did not refer to smoke and were not exposed to SHS was below the quantification level of 4.0 ng/ml, whereas in non-smokers exposed to SHS, it was 7.6 ng/ml. Among all smokers, the UC median level was 1744.3 ng/ml (table 2). Occasional smokers had a median level of 260.7 ng/ml. Among daily smokers, statistically significant differences were observed between UC concentration and the number of cigarettes smoked per day (p<0.001), showing a clear dose-response pattern (not statistically tested). In the same way, in non-smokers, there were statistically significant differences between UC levels and the number of sources of exposure to SHS, which are, work, home and elsewhere in leisure time (p<0.001), with a progressive dose-response pattern (not tested, neither). Figure 2 shows the different distribution patterns of UC among non-smokers, exposed or not to SHS, and occasional and daily smokers.

Table 2

Active smoking and exposure to SHS in pregnant women in the INfancia y Medio Ambiente cohort. Median levels of urinary cotinine (ng/ml) at the third trimester of pregnancy

Figure 2

Distribution of urinary cotinine (ng/ml) according to active or passive tobacco exposure in pregnant women from the INfancia y Medio Ambiente cohort. Me, median; SHS, second-hand smoking; SRS Occas, self-reported smoking, occasional; SRS Daily, self reported smoking, daily.

Self-reported smoking and misclassification

Among the 2263 women studied, 1755 (77.6%) reported that they did not smoke and had UC levels below 50 ng/ml (true negative). A further 18 (0.8%) also had UC levels under 50 ng/ml despite claiming to smoke, though 13 of these claimed to be occasional smokers. On the other hand, 90 women (3.9%) reported that they did not smoke but were found to have UC levels above 50 ng/ml and were considered as misclassified, and finally, 400 women (17.7%) were true positive. Table 3 shows the ORs of the variables associated with smoking and misclassification, before and after adjusting. In the adjusted model, the risks of smoking and misclassification were associated with low educational level, country of birth and exposure to SHS. Age was related only to misclassification risk. In regard to smoking history, only smoking at the beginning of pregnancy was associated with misclassification. The year of urine sampling and the social class were statistically associated only in the unadjusted analysis. Adding women misclassified to self-reported smokers, the pattern of the association found with self-reported smoking did not vary.

Table 3

Unadjusted and adjusted ORs and variables associated with smoking

Cut-off points of UC for smoking

Optimal cut-off points for distinguishing non-smokers from smokers (daily and occasional), calculated by Youden's index, was 82 ng/ml, with a sensitivity of 95.2%, specificity of 96.6% and AUC of 0.986 (95% CI 0.982 to 0.990) (table 4). Sensitivity and specificity for the cut-off points of 50 and 100 ng/ml were quite close to that of 82 ng/ml. Results of sensitivity analysis are shown in the online supplementary table. The exclusion of cases more prone to bias (317 women who declare to have stopped smoking during pregnancy or 35 self-reported non-smokers with implausible high UC levels) did not improve substantially the validation parameters of the tests.

Table 4

Parameters for assessing the optimal cut-off point for urinary cotinine (ng/ml) obtained by Youden's index, as well as the levels of 25, 50 and 100 ng/ml, for classifying pregnant women as regular or occasional smokers

Youden's index and AUC for daily smoking were higher, with a cut-off point of 115 ng/ml. Occasional smoking was analysed by excluding from the analysis the 381 women who admitted that they smoked regularly at the third trimester of pregnancy. The optimal cut-off point for discriminating occasional smokers from non-smokers was 27 ng/ml (95% CI 11 to 43), with a sensitivity and specificity of 89.2% and 89.7%, respectively. The exclusion of women who declared having quit smoking during pregnancy improved the specificity to 91.8%, but it did not almost change Youden's index or the sensitivity. Excluding non-SHS-exposed among non-smokers, the optimal cut-off point was 19 ng/ml (95% CI 11 to 33), improving the specificity to 93.7% and the positive predictive value (probability of smoking status being a positive test) to 41.2%. Nevertheless, these low positive-predictive values are a consequence, above all, of the low prevalence of occasional smoking in this sample.

Women not exposed to SHS compared with all smokers, daily or occasional, had a lower cut-off point of 42 ng/ml (95% CI 27 to 57), whereas, for those exposed to one or to two or more sources of SHS, the cut-off points were 82 (95% CI 55 to 136) and 106 ng/ml (95% CI 79 to 201), respectively.

Discussion

Main findings in relation to the literature

The prevalence of smoking in pregnant women at the third trimester was 18.5%. In this later stage, the prevalence of active smoking increased up to 22.5%, if women who did not report smoking but had UC levels above 50 ng/ml were reclassified as smokers, assuming that false-positives were due to maternal misreporting of smoking status. Prevalence of self-reported smokers and misclassified in our study is close to the ones referred by Kendrick et al6 and Lindqvist et al,7 and the smoking rate and UC levels are lower than that showed by Pickett et al.15 Our study had, nevertheless, a lower rate of smoking misreporting than other studies.2–8

There was a clear relationship between UC and smoking dose among smokers, and with the number of sources of exposure to SHS among non-smokers. Specifically, those who smoked 10 or more cigarettes per day had median UC levels of 3033 ng/ml, whereas the levels were 260 ng/ml for occasional smokers and less than 17 ng/ml for non-smokers, increasing with the number of sources of exposure to SHS. These data reinforce the validity of UC also as an indicator of exposure to SHS.10

England et al13 indicated that few studies have identified differences between misclassified and self-reported smokers and the way in which this would affect epidemiological studies. Our study shows similar patterns of association, and both self-reported smoking and misclassification were strongly associated with various predictive variables. In particular, we found a higher risk of smoking and misclassification among women with low education level. These results are consistent with those reported by other authors.6 ,14 ,24 We also found a higher risk of smoking and misclassification in women from Europe and women exposed to SHS in different places. Women younger than 24 years had an increased risk of misreport in their smoking, as indicated by Dietz et al.4 In this study, exposure to SHS was associated with smoking. In other words, there were more smoking people around pregnant women who smoked. In addition, misclassification was significantly associated with exposure to SHS at home. Jhun et al14 and Orr et al25 also showed higher prevalence of smoking among pregnant women whose partners smoked at home. Having smoked previously was associated with a higher probability of misreporting the habit, as observed by England et al.13

This work showed an optimal cut-off point for discriminating pregnant women smokers from non-smokers of 82 ng/ml, with a CI of 42 to 136 ng/ml. Some studies proposed a cut-off of 50 ng/ml,13–16 coherent with the women not SHS exposed in this study. Other studies proposed cut-off points of 79 ng/ml18 and 85 ng/ml,6 closer to the smoking dose and SHS exposure in our study sample. In our study population, both the prevalence of smoking and of SHS is high, and this can explain, in part, why our optimal cut-off point is higher than those reported in other studies.13–17 This is also supported by the fact that the optimal cut-off point decreased to 42 ng/ml (27– 57) when the analysis was restricted to women who reported no SHS exposure and increased according to the number of sources reported. The validity of 27 ng/ml (11– 43) as a cut-off point for differentiating occasional smokers from non-smokers was lower than that for differentiating daily smokers, and it could depend on SHS exposure and on the time spent from the last cigarette smoked, given the faster elimination of cotinine in pregnant women,10–12 information not collected in this study. There are no validation studies of cotinine in different biological matrices, blood (plasma or serum), saliva or urine,9 ,16 so it cannot be established which biomarker is the most reliable.

Limitations of the study

The current study has several limitations. From the eligible population, the participation rate was 56%, and 85.6% of the women who agreed to participate completed the study. Therefore, the final study sample might not be fully representative of all pregnant women in the study areas, but its internal validity (absence of bias) is not necessarily affected. There were other likely sources of misclassification in addition to maternal misreporting of smoking status as misclassification of non-smokers as smokers because of the high degree of exposure to SHS. On the other hand, women who smoked occasionally but reported to be non-smokers might have low UC concentrations if they had not smoked recently, and their self-report and UC levels would be in agreement.

No information about last cigarette or last SHS exposure was obtained. We lost the opportunity of analysing this variable in the evolution of the UC, showing its influence in false negatives, above all, and especially relevant for occasional smokers.

Since the optimal cut-off point for UC is determined using self-reported smoking status as the gold standard, the validity of this assumption is important. On the one hand, it is unlikely that a non-smoking woman declared to be a smoker because a battery of items should be completed detailing smoking habits in this case. On the other hand, however, it is possible that some smokers did not reveal their habits. In order to minimise this type of bias, we excluded, in the additional analysis, self-reported non-smokers with implausibly high UC levels. In another sensitivity analysis, we excluded self-reported non-smokers who claimed to stop smoking during pregnancy, since these cases are at a higher risk of misclassification, as reported in table 3; the optimal cut-off point did not change after these exclusions. In general terms, the AUC shows a good overall accuracy, and we think that self-reported smoking is a reliable measure in this study. If some kind of misclassification occurs, it would lead to a shift towards the right in both distributions and a slight overestimation of the optimal cut-off point as a result.

One of the main strengths of this study was the possibility of assessing the role of baseline exposures to SHS in the estimate of cut-offs, given the detailed information collected on SHS exposure and its elevated prevalence. The confirmation that the cut-offs would differ according to the level of exposure to SHS emphasises the need of taking it into account, especially in countries with elevated SHS exposure.

Implications for practice

This study shows that the efforts made to encourage women to give up smoking before or during pregnancy are not sufficient or particularly effective, given that at least 18.5% of the pregnant women smoked in the third trimester. The results of this study indicate that the groups to which the most effort should be directed are young women, those of a European origin and those from a low social class. Further, the association observed in this study between active smoking of pregnant women and the presence of smokers in their close environment supports the hypothesis that this factor makes it more difficult to stop smoking.26 It is necessary to undertake effective programmes for reducing smoking before and during pregnancy, reaching also misclassified, and to reduce SHS exposure, in order to prevent risks for women and to the fetus.

Conclusion

Smoking is an important risk factor for health and development and should be taken into account as a confounder when analysing the potential effects of environmental contaminants in studies like the INMA project. Having a reliable marker like UC and a valid cut-off point that is able to discriminate regular or occasional smokers from non-smokers are critical issues. The cut-off point of 82 ng/ml showed a good validity for discriminating smokers from non-smokers in our study sample, whereas 27 ng/ml is the optimal point for discriminating occasional smokers from non-smokers. It should be emphasised that cut-offs would differ based on baseline exposure to SHS, and this should be taken into account when selecting reference cut-offs for specific populations.

Acknowledgments

The authors are grateful to all fieldworkers for their assistance in administering the questionnaires. A full listing of the INMA project researchers can be found at http://www.proyectoinma.org/presentacioninma/listado-investigadores/en_listado-investigadores.html.

References

View Abstract
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Footnotes

  • Contributors JJA, MM and MR designed the study and analysed the data. AMC and ME analysed cotinine in urine samples. MJL, AMC, LSM, MG, AF-S, ME, AL, AT and FB revised the design of the study and the results. JJA wrote the manuscript and the other authors participated in reviews of the different drafts and approved the final version.

  • Funding The INMA project is funded by grants from Instituto de Salud Carlos III (Red INMA G03/176 and CB06/02/0041) and Fundación Roger Torné. The studies in the specific regions were funded by the Spanish Ministry of Health (FIS 03/1615, 04/1436, 04/1509, 04/1112, 04/1931, 05/1079, 05/1052, 06/0867,06/1213, 07/0314, 08/1151, 09/02647, 04/2018, 09/02311), the Generalitat de Catalunya (CIRIT 1999SGR00241), the Diputación Foral de Gipuzkoa (DFG06/004), the Department of Health of the Basque Government (2005111093), the Regional Government of Andalucía (SAS 07/183), Obra social Cajastur, University of Oviedo and the Conselleria de Sanitat Generalitat Valenciana. http://www.proyectoinma.org/instituciones-participantes/en_entidades-colaboradoras/.

  • Patient consent Obtained.

  • Ethics approval This study was conducted with the approval for each of the four cohorts and the hospital ethics committee of each centre.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.